Premium
Keros Therapeutics Inc (KROS)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candida... Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.35 | -2.93378038558 | 11.93 | 12.035 | 10.62 | 765653 | 11.35285966 | CS |
| 4 | 1.3557 | 13.2595874534 | 10.2243 | 12.28 | 10.182 | 972736 | 11.11066483 | CS |
| 12 | -5.13 | -30.7001795332 | 16.71 | 17.6381 | 9.775 | 1398284 | 11.83270015 | CS |
| 26 | -45.51 | -79.7162375197 | 57.09 | 72.37 | 9.775 | 1041803 | 22.38755832 | CS |
| 52 | -55.44 | -82.7215756491 | 67.02 | 72.37 | 9.775 | 682597 | 29.9944414 | CS |
| 156 | -39.81 | -77.4664331582 | 51.39 | 73 | 9.775 | 390503 | 35.64987851 | CS |
| 260 | -8.52 | -42.3880597015 | 20.1 | 88.8 | 9.775 | 291728 | 38.62853428 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
